መነሻ › ትሪፕል-ኔጌቲቭ የደረት ካንሰር › ሜሪላንድ › Baltimore
በBaltimore፣ MD ለትሪፕል-ኔጌቲቭ የደረት ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለትሪፕል-ኔጌቲቭ የደረት ካንሰር የሚደረጉ 12 ጥናቶች በBaltimore እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- MedStar Franklin Square Medical Center ( Site 0031), Baltimore
- MedStar Good Samaritan Hospital ( Site 0079), Baltimore
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Mercy Medical Center - Baltimore ( Site 0015), Baltimore
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- United Theranostics, Glen Burnie · 9 ማይል ርቀት
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Sinai Hospital of Baltimore, Inc., Baltimore
- St. Agnes Hospital, Baltimore
- Johns Hopkins Medicine - The Sidney Kimmel Comprehensive Cancer Center, Baltimore
- እና 1 ተጨማሪ
PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Local Institution - 1035, Baltimore
Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- United Theranostics, Glen Burnie · 9 ማይል ርቀት
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Maryland Medical Center (UMMC), Baltimore
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
በሌሎች ከተሞች ለትሪፕል-ኔጌቲቭ የደረት ካንሰር የሚደረጉ ጥናቶች
- Houston, TX42 ጥናቶች
- New York City, NY31 ጥናቶች
- Nashville, TN28 ጥናቶች
- Los Angeles, CA27 ጥናቶች
- Boston, MA26 ጥናቶች
- San Antonio, TX23 ጥናቶች
- St. Louis, MO21 ጥናቶች
- Arlington, VA20 ጥናቶች
- Atlanta, GA20 ጥናቶች
- Dallas, TX18 ጥናቶች
- Chicago, IL16 ጥናቶች
- Columbus, OH16 ጥናቶች
በBaltimore ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር60 ጥናቶች
- የጡንቻ ካንሰር47 ጥናቶች
- የፕሮስቴት ካንሰር43 ጥናቶች
- የሳንባ ካንሰር40 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)37 ጥናቶች
- የፓንክሪያስ ካንሰር31 ጥናቶች
- የኮሎሬክታል ካንሰር31 ጥናቶች
- Metastatic Cancer28 ጥናቶች
- ከባድ ሰውነት26 ጥናቶች
- የሽንት ፊኛ ካንሰር24 ጥናቶች
- የልብ ድካም24 ጥናቶች
- የእንቁላል ካንሰር22 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።